For diverse patient populations who are historically marginalized within health care, student-run clinics may offer a ...

Gilead Sciences said on Saturday that it entered into a partnership with Denmark's LEO Pharma to develop programs to treat ...

Gilead Sciences (GILD) partners with LEO Pharma in a $1.7B agreement to develop anti-inflammatory drugs. Read more here.

Gilead Sciences, Inc. (GILD) and LEO Pharma entered strategic partnership to develop and commercialize LEO Pharma's small molecule ...

Sun Pharmaceuticals has emerged as a key speciality player, with global speciality revenues rising from 7% in FY18 to 18% in ...

Analysts at Zacks Research upped their FY2024 EPS estimates for Nektar Therapeutics in a report issued on Monday, January 6th. Zacks Research analyst K. Das now forecasts that the biopharmaceutical ...

We all crave for the slow life. A cup of coffee, as lo-fi music flows through the speakers, reading a book, making notes in a ...

CAGE Bio begins phase 2b clinical trial for CGB-500, a breakthrough topical JAK inhibitor for moderate to severe atopic dermatitis: San Carlos, California Saturday, January 11, 20 ...